Question · asked by 1 review
Intranasal corticosteroids vs placebo: Disease‐specific health‐related quality of life Short Form 12 (SF‐12v2) (range 0 to 800)
- Population
- adults and children > 12 with non‐allergic rhinitis
- Intervention
- Intranasal corticosteroids
- Comparison
- placebo
- Outcome
- Disease‐specific health‐related quality of life Short Form 12 (SF‐12v2) (range 0 to 800)
What each review found
Include earlier review versions| Finding | Effect | Studies | GRADE certainty |
|---|---|---|---|
Intranasal corticosteroids vs placebo Disease‐specific health‐related quality of life Short Form 12 (SF‐12v2) (range 0 to 800) · adults and children > 12 with non‐allergic rhinitis Intranasal corticosteroids for non‐allergic rhinitis (2019) · Cochrane Headline outcomes only | no estimate extracted | 1 study · 49 participants | Low |
Findings are shown side by side, never pooled across reviews.
The reviews
| Review | Searched up to | Included studies | AMSTAR 2 |
|---|---|---|---|
| Intranasal corticosteroids for non‐allergic rhinitis 2019 · Cochrane Headline outcomes only | Not reported | Not extracted | Not assessed |
How reviews are matched to this question
Reviews word the same question differently. Four decision models (TypeSafe's Jev, Liquid AI's d1-ultra, SubQ Snap and Baseten's Elephant) judged each wording of the population, intervention, comparator and outcome against the others; two wordings count as the same when at least three of them agree and none clearly disagrees, and findings count as this question only when all four elements match. Timing, setting and subgroup never split a question: they are shown on each finding.